John Hancock Multifactor Healthcare ETF
JHMH
JHMH was delisted on the 24th of October, 2022.
0 hedge funds and large institutions have $0 invested in John Hancock Multifactor Healthcare ETF in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.
100% less funds holding
Funds holding: 22 → 0 (-22)
100% less capital invested
Capital invested by funds: $21.5M → $0 (-$21.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 20
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$4.21M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
-$2.86M |
| 3 |
BAM
Bellevue Asset Management
Bellevue,
Washington
|
-$2.69M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.68M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.67M |
JHMH Hedge Fund Activity: Q4 2022 in Review
0 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in John Hancock Multifactor Healthcare ETF (JHMH) for Q4 2022, worth a combined $0 — down 100% from $21.5M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of JHMH and 0 opened new positions — a net loss of 20 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was LPL Financial, exiting entirely with an estimated $4.21M sold.
- 0 institutional investors held John Hancock Multifactor Healthcare ETF (JHMH) as of Q4 2022, down from 22 in Q3 2022.
- Funds reported $0 of John Hancock Multifactor Healthcare ETF stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new John Hancock Multifactor Healthcare ETF positions in Q4 2022 and 20 closed out, a net change of -20 holders.
- The largest John Hancock Multifactor Healthcare ETF seller in Q4 2022 was LPL Financial, an estimated $4.21M sold.
Based on aggregated 13F filings for Q4 2022.